Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s. They represent a huge step forward in research because they target a known cause of the disease, ...

Two drugs to treat Alzheimer’s disease have been rejected for use on the NHS because their benefits are “too small” to justify their cost, the health spending watchdog has said.

No stranger to oversight errors, the Nursing and Midwifery Council has now been revealed to have allowed hundreds of ...

Duchenne muscular dystrophy families are sharing stories about Elevidys complications on social media. But they aren’t ...

Treating rare diseases can be complicated at the best of times, and it gets even more complicated when different patients ...

A Henrico County nursing home is facing regulatory enforcement action after it was cited for serious safety violations by ...

The FDA approval of Vimkunya has given the chikungunya vaccine’s owner, Bavarian Nordic, an extra financial windfall. | The ...

I am upgrading Dyne Therapeutics stock to a 'Buy' rating due to promising late-stage DM1 and DMD drug candidates and ...

Living near heavily microplastic-polluted waters along the United States coastline may significantly raise the risk of ...

The liver is one of the hardest working organs in the human body. It detoxifies harmful substances, helps with digestion, ...

There was a big discovery of a disease that is being spread throughout New York State that has people very concerned and ...